Որոնման արդյունքները - Tyler Hycner
- Ցուցադրվում են 1 - 2 արդյունքները 2
-
1
Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma Andrzej Jakubowiak, Jagoda Jasielec, Cara A. Rosenbaum, Craig E. Cole, Ajai Chari, Joseph Mıkhael, Jennifer Nam, Amanda McIver, Erica Severson, Leonor A Stephens, Kathryn M. Tinari, Shaun Rosebeck, Todd M. Zimmerman, Tyler Hycner, Agata Turowski, Theodore Karrison, Jeffrey A. Zonder
Հրապարակվել է 2019Artigo -
2
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma Jagoda Jasielec, Tadeusz Kubicki, Noopur Raje, Ravi Vij, Donna Reece, Jesús G. Berdeja, Benjamin A. Derman, Cara A. Rosenbaum, Paul G. Richardson, Sandeep Gurbuxani, Sarah Major, Brittany Wolfe, Andrew Stefka, Leonor A Stephens, Kathryn M. Tinari, Tyler Hycner, Alexandra E. Rojek, Dominik Dytfeld, Kent A. Griffith, Todd M. Zimmerman, Andrzej Jakubowiak
Հրապարակվել է 2020Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Carfilzomib
Internal medicine
Lenalidomide
Medicine
Multiple myeloma
Oncology
Astrobiology
Autologous stem-cell transplantation
Biology
Chemotherapy
Clinical endpoint
Clinical trial
Daratumumab
Dexamethasone
Leukemia
Minimal residual disease
Neutropenia
Pharmacology
Refractory (planetary science)
Regimen
Surgery
Transplantation